Travere Therapeutics Inc (TVTX) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $8,353,941.05
Most recent insider trade:
- Oct. 4, 2024
Most active insider trader:
- Eric M Dube
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 24, 2022 | SVP | 1,875 | $24.98 | Sell | $46,837.50 | |
Jan. 24, 2022 | CFO | 2,063 | $24.98 | Sell | $51,533.74 | |
Jan. 24, 2022 | CEO | 7,873 | $24.98 | Sell | $196,667.54 | |
Jan. 24, 2022 | CAO | 934 | $24.58 | Sell | $22,957.72 | |
Jan. 11, 2022 | CFO | 7,500 | $27.40 | Sell | $205,500.00 | |
Jan. 11, 2022 | SVP | 5,000 | $27.40 | Sell | $137,000.00 | |
Jan. 4, 2022 | CEO | 4,832 | $30.43 | Sell | $147,037.76 | |
Nov. 16, 2021 | Director | 31,800 | $29.39 | Sell | $934,602.00 | |
Nov. 5, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
Oct. 7, 2021 | Director | 60,000 | $26.25 | Sell | $1,575,000.00 | |
Aug. 17, 2021 | Insider | 1,407 | $17.12 | Sell | $24,087.84 | |
Aug. 17, 2021 | CEO | 7,836 | $17.12 | Sell | $134,152.32 | |
July 28, 2021 | Insider | 1,250 | $13.81 | Sell | $17,262.50 | |
June 2, 2021 | CEO | 9,562 | $14.62 | Sell | $139,796.44 | |
April 16, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
March 17, 2021 | Director | 17,727 | $27.44 | Sell | $486,428.88 | |
Feb. 18, 2021 | SVP | 2,500 | $28.01 | Sell | $70,025.00 | |
Feb. 3, 2021 | SVP | 3,175 | $28.91 | Sell | $91,789.25 | |
Feb. 3, 2021 | CFO | 3,625 | $28.91 | Sell | $104,798.75 | |
Feb. 3, 2021 | Insider | 1,813 | $28.91 | Sell | $52,413.83 | |
Feb. 3, 2021 | CEO | 2,406 | $28.91 | Sell | $69,557.46 |
Insiders are selling Travere Therapeutics Inc stock.
The insider traders at Travere Therapeutics Inc are: Eric M Dube, Christopher R Cline, Sandra Calvin, Peter Heerma, William E Rote, Steve Aselage, Elizabeth E Reed, Laura Clague, Jula Inrig, Jeffrey A Meckler, Gary A Lyons, Noah L. Rosenberg, and Noah L Rosenberg
The most active insider trader at Travere Therapeutics Inc is Eric M Dube with 13 trades.
Steve Aselage has sold the most Travere Therapeutics Inc stock with a total value of $3,633,518.88.
The most recent insider trade for Travere Therapeutics Inc was on Oct. 4, 2024.
The single biggest insider sell for Travere Therapeutics Inc was from Steve Aselage with a total value of $1,575,000.00 on Oct. 7, 2021.